R 68151
| Code | Size | Price |
|---|
| TAR-T26021-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
R 68151 is used as a potent 5-lipoxygenase inhibitor.
CAS:
138331-04-1
Formula:
C23H28N4O2S
Molecular Weight:
424.56
Purity:
0.98
SMILES:
CCN(C(N1c2ccc(N3CCN(c4ccc(O)cc4)CC3)cc2)=S)C(C)(C)C1=O
References
1. Zhu YI, Stiller MJ. Preview of potential therapeutic applications of leukotriene B4 inhibitors in dermatology. Skin Pharmacol Appl Skin Physiol. 2000 Sep-Oct;13(5):235-45. Review. PubMed PMID: 10940813.
2. Mari?n K, Morren M, Degreef H, De Doncker P, Rooman RP, Cauwenbergh G. Treatment of hyperkeratotic skin diseases with R 68151, a topical 5-lipoxygenase inhibitor: four case reports. Arch Dermatol. 1992 Jul;128(7):993-4. PubMed PMID: 1626974.
3. Degreef H, Dockx P, De Doncker P, De Beule K, Cauwenbergh G. A double-blind vehicle-controlled study of R 68 151 in psoriasis: a topical 5-lipoxygenase inhibitor. J Am Acad Dermatol. 1990 May;22(5 Pt 1):751-5. PubMed PMID: 2189906.